| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 4.44e-28 | 46 | 41 | 14 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 7.43e-19 | 188 | 41 | 14 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 SNTB1 CLTA | 7.81e-12 | 891 | 41 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXD2 GATA4 MYCL SKOR1 POU3F1 VAX1 POU3F3 POU5F1B FOXK2 CEBPA PHOX2B HSF5 KLF2 | 6.83e-07 | 1244 | 41 | 13 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXD2 GATA4 MYCL SKOR1 POU3F1 VAX1 POU3F3 POU5F1B FOXK2 CEBPA PHOX2B HSF5 KLF2 | 8.71e-07 | 1271 | 41 | 13 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXD2 GATA4 MYCL SKOR1 POU3F1 VAX1 POU3F3 POU5F1B FOXK2 CEBPA PHOX2B HSF5 KLF2 | 4.07e-06 | 1459 | 41 | 13 | GO:0000977 |
| GeneOntologyMolecularFunction | HMG box domain binding | 1.38e-05 | 23 | 41 | 3 | GO:0071837 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | FOXD2 GATA4 MYCL SKOR1 POU3F1 VAX1 POU3F3 POU5F1B FOXK2 CEBPA PHOX2B KLF2 | 1.72e-05 | 1412 | 41 | 12 | GO:0000981 |
| GeneOntologyMolecularFunction | heparin binding | 4.41e-05 | 192 | 41 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 2.12e-04 | 268 | 41 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 3.16e-04 | 13 | 41 | 2 | GO:0001162 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 4.99e-04 | 323 | 41 | 5 | GO:1901681 | |
| GeneOntologyMolecularFunction | intronic transcription regulatory region sequence-specific DNA binding | 5.49e-04 | 17 | 41 | 2 | GO:0001161 | |
| GeneOntologyMolecularFunction | SMAD binding | 7.31e-04 | 86 | 41 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 9.24e-04 | 560 | 41 | 6 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 9.77e-04 | 566 | 41 | 6 | GO:0001216 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 4.11e-03 | 320 | 41 | 4 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 4.39e-03 | 326 | 41 | 4 | GO:0001217 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 4.85e-03 | 167 | 41 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | integrin binding | 5.52e-03 | 175 | 41 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 5.97e-03 | 180 | 41 | 3 | GO:0004866 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 6.63e-03 | 187 | 41 | 3 | GO:0030414 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 8.23e-15 | 377 | 41 | 14 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 8.54e-15 | 378 | 41 | 14 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 8.86e-15 | 379 | 41 | 14 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 4.02e-07 | 76 | 41 | 5 | GO:0030199 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.58e-06 | 12 | 41 | 3 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 5.83e-06 | 18 | 41 | 3 | GO:0038065 | |
| GeneOntologyBiologicalProcess | cellular response to acid chemical | 2.57e-05 | 177 | 41 | 5 | GO:0071229 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | GATA4 SKOR1 CDKN2A POU3F1 VAX1 POU3F3 POU5F1B FOXK2 CEBPA SF1 KLF2 | 6.38e-05 | 1399 | 41 | 11 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | GATA4 SKOR1 CDKN2A POU3F1 VAX1 POU3F3 POU5F1B FOXK2 CEBPA SF1 KLF2 | 6.98e-05 | 1413 | 41 | 11 | GO:1902679 |
| GeneOntologyBiologicalProcess | response to acid chemical | 8.56e-05 | 228 | 41 | 5 | GO:0001101 | |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 1.72e-04 | 10 | 41 | 2 | GO:0032836 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 1.82e-04 | 1053 | 41 | 9 | GO:0000122 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 1.89e-04 | 270 | 41 | 5 | GO:0007160 | |
| GeneOntologyBiologicalProcess | cellular response to amino acid stimulus | 2.89e-04 | 161 | 41 | 4 | GO:0071230 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXD2 GATA4 CDKN2A POU3F1 POU3F3 POU5F1B FOXK2 CEBPA PHOX2B KLF2 | 3.05e-04 | 1390 | 41 | 10 | GO:0045944 |
| GeneOntologyBiologicalProcess | respiratory system development | 3.31e-04 | 305 | 41 | 5 | GO:0060541 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | 5.39e-04 | 1220 | 41 | 9 | GO:0051093 | |
| GeneOntologyCellularComponent | collagen trimer | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 GLDN COL16A1 COL17A1 COL28A1 | 3.82e-26 | 88 | 41 | 15 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL11A1 COL11A2 COL28A1 | 8.89e-23 | 21 | 41 | 10 | GO:0098644 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 1.18e-15 | 332 | 41 | 14 | GO:0005788 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 7.20e-13 | 530 | 41 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 1.26e-11 | 656 | 41 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 1.31e-11 | 658 | 41 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.77e-11 | 12 | 41 | 5 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.77e-11 | 12 | 41 | 5 | GO:0098643 | |
| GeneOntologyCellularComponent | basement membrane | 8.68e-11 | 122 | 41 | 8 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.90e-10 | 6 | 41 | 4 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 8.86e-10 | 8 | 41 | 4 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 8.86e-10 | 8 | 41 | 4 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 8.86e-10 | 8 | 41 | 4 | GO:0098645 | |
| GeneOntologyCellularComponent | chromatin | FOXD2 GATA4 MYCL CDKN2A POU3F1 VAX1 POU3F3 POU5F1B FOXK2 CEBPA PHOX2B KLF2 | 1.74e-05 | 1480 | 41 | 12 | GO:0000785 |
| GeneOntologyCellularComponent | collagen type V trimer | 2.25e-05 | 4 | 41 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 3.74e-05 | 5 | 41 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL11A1 COL11A2 COL28A1 | 4.01e-04 | 1187 | 41 | 9 | GO:0099081 |
| GeneOntologyCellularComponent | transcription regulator complex | 5.95e-03 | 596 | 41 | 5 | GO:0005667 | |
| GeneOntologyCellularComponent | vesicle coat | 7.66e-03 | 67 | 41 | 2 | GO:0030120 | |
| HumanPheno | Lenticonus | 8.23e-06 | 10 | 22 | 3 | HP:0001142 | |
| HumanPheno | Glomerular basement membrane lamellation | 5.33e-05 | 3 | 22 | 2 | HP:0030034 | |
| HumanPheno | Anterior lenticonus | 5.33e-05 | 3 | 22 | 2 | HP:0011501 | |
| HumanPheno | Thin glomerular basement membrane | 5.33e-05 | 3 | 22 | 2 | HP:0012577 | |
| HumanPheno | Abnormality of lens shape | 5.47e-05 | 18 | 22 | 3 | HP:0011526 | |
| HumanPheno | Glomerular deposits | 7.60e-05 | 20 | 22 | 3 | HP:0030949 | |
| HumanPheno | Cutaneous melanoma | 1.02e-04 | 22 | 22 | 3 | HP:0012056 | |
| HumanPheno | Genital blistering | 1.06e-04 | 4 | 22 | 2 | HP:0031464 | |
| HumanPheno | Degenerative vitreoretinopathy | 1.77e-04 | 5 | 22 | 2 | HP:0007964 | |
| MousePheno | sensorineural hearing loss | 1.25e-04 | 37 | 37 | 3 | MP:0004740 | |
| MousePheno | sensorineural hearing impairment | 1.35e-04 | 38 | 37 | 3 | MP:0006329 | |
| MousePheno | podocyte foot process effacement | 1.35e-04 | 38 | 37 | 3 | MP:0008140 | |
| MousePheno | podocyte hypertrophy | 1.42e-04 | 7 | 37 | 2 | MP:0011871 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 2.10e-04 | 44 | 37 | 3 | MP:0011348 | |
| MousePheno | abnormal hyaline cartilage morphology | 2.40e-04 | 46 | 37 | 3 | MP:0006429 | |
| MousePheno | kidney failure | 2.40e-04 | 46 | 37 | 3 | MP:0003606 | |
| MousePheno | dermal-epidermal separation | 2.43e-04 | 9 | 37 | 2 | MP:0011160 | |
| Domain | Collagen | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 GLDN COL16A1 COL17A1 COL28A1 | 7.42e-26 | 85 | 40 | 15 | PF01391 |
| Domain | Collagen | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 GLDN COL16A1 COL17A1 COL28A1 | 7.42e-26 | 85 | 40 | 15 | IPR008160 |
| Domain | C4 | 2.70e-10 | 6 | 40 | 4 | SM00111 | |
| Domain | - | 2.70e-10 | 6 | 40 | 4 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.70e-10 | 6 | 40 | 4 | IPR001442 | |
| Domain | NC1_IV | 2.70e-10 | 6 | 40 | 4 | PS51403 | |
| Domain | C4 | 2.70e-10 | 6 | 40 | 4 | PF01413 | |
| Domain | TSPN | 1.14e-09 | 23 | 40 | 5 | SM00210 | |
| Domain | NC1_FIB | 5.89e-09 | 11 | 40 | 4 | PS51461 | |
| Domain | Fib_collagen_C | 5.89e-09 | 11 | 40 | 4 | IPR000885 | |
| Domain | Fib_collagen_C | 5.89e-09 | 11 | 40 | 4 | PD002078 | |
| Domain | COLFI | 5.89e-09 | 11 | 40 | 4 | SM00038 | |
| Domain | COLFI | 5.89e-09 | 11 | 40 | 4 | PF01410 | |
| Domain | Laminin_G | 1.47e-07 | 58 | 40 | 5 | IPR001791 | |
| Domain | POU | 5.00e-06 | 16 | 40 | 3 | SM00352 | |
| Domain | POU_2 | 5.00e-06 | 16 | 40 | 3 | PS00465 | |
| Domain | Pou | 5.00e-06 | 16 | 40 | 3 | PF00157 | |
| Domain | POU_dom | 5.00e-06 | 16 | 40 | 3 | IPR000327 | |
| Domain | POU_3 | 5.00e-06 | 16 | 40 | 3 | PS51179 | |
| Domain | POU_1 | 5.00e-06 | 16 | 40 | 3 | PS00035 | |
| Domain | POU | 6.06e-06 | 17 | 40 | 3 | IPR013847 | |
| Domain | - | 2.57e-05 | 27 | 40 | 3 | 1.10.260.40 | |
| Domain | TF_POU_3 | 2.68e-05 | 4 | 40 | 2 | IPR016362 | |
| Domain | Lambda_DNA-bd_dom | 3.20e-05 | 29 | 40 | 3 | IPR010982 | |
| Domain | Homeobox_CS | 4.60e-05 | 186 | 40 | 5 | IPR017970 | |
| Domain | - | 4.99e-05 | 95 | 40 | 4 | 2.60.120.200 | |
| Domain | CTDL_fold | 7.94e-05 | 107 | 40 | 4 | IPR016187 | |
| Domain | Laminin_G_2 | 8.51e-05 | 40 | 40 | 3 | PF02210 | |
| Domain | ConA-like_dom | 9.97e-05 | 219 | 40 | 5 | IPR013320 | |
| Domain | LamG | 1.13e-04 | 44 | 40 | 3 | SM00282 | |
| Domain | Homeobox | 1.36e-04 | 234 | 40 | 5 | PF00046 | |
| Domain | HOMEOBOX_1 | 1.42e-04 | 236 | 40 | 5 | PS00027 | |
| Domain | HOX | 1.44e-04 | 237 | 40 | 5 | SM00389 | |
| Domain | Homeobox_dom | 1.50e-04 | 239 | 40 | 5 | IPR001356 | |
| Domain | HOMEOBOX_2 | 1.50e-04 | 239 | 40 | 5 | PS50071 | |
| Domain | VWA | 2.33e-04 | 56 | 40 | 3 | PF00092 | |
| Domain | - | 3.29e-04 | 283 | 40 | 5 | 1.10.10.60 | |
| Domain | - | 5.31e-04 | 74 | 40 | 3 | 3.40.50.410 | |
| Domain | - | 6.70e-04 | 18 | 40 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 6.70e-04 | 18 | 40 | 2 | IPR020901 | |
| Domain | Homeodomain-like | 6.80e-04 | 332 | 40 | 5 | IPR009057 | |
| Domain | VWFA | 7.17e-04 | 82 | 40 | 3 | PS50234 | |
| Domain | BPTI_KUNITZ_2 | 7.47e-04 | 19 | 40 | 2 | PS50279 | |
| Domain | Kunitz_BPTI | 7.47e-04 | 19 | 40 | 2 | PF00014 | |
| Domain | BPTI_KUNITZ_1 | 7.47e-04 | 19 | 40 | 2 | PS00280 | |
| Domain | VWA | 7.69e-04 | 84 | 40 | 3 | SM00327 | |
| Domain | Kunitz_BPTI | 1.10e-03 | 23 | 40 | 2 | IPR002223 | |
| Domain | VWF_A | 1.24e-03 | 99 | 40 | 3 | IPR002035 | |
| Domain | TF_fork_head_CS_2 | 4.36e-03 | 46 | 40 | 2 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 4.55e-03 | 47 | 40 | 2 | IPR018122 | |
| Domain | FORK_HEAD_3 | 4.94e-03 | 49 | 40 | 2 | PS50039 | |
| Domain | FH | 4.94e-03 | 49 | 40 | 2 | SM00339 | |
| Domain | FORK_HEAD_1 | 4.94e-03 | 49 | 40 | 2 | PS00657 | |
| Domain | FORK_HEAD_2 | 4.94e-03 | 49 | 40 | 2 | PS00658 | |
| Domain | Forkhead | 4.94e-03 | 49 | 40 | 2 | PF00250 | |
| Domain | Fork_head_dom | 4.94e-03 | 49 | 40 | 2 | IPR001766 | |
| Domain | - | 1.13e-02 | 218 | 40 | 3 | 1.10.10.10 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 2.00e-28 | 41 | 33 | 14 | MM15538 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 6.50e-28 | 44 | 33 | 14 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 1.25e-25 | 61 | 33 | 14 | MM14637 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 5.37e-25 | 67 | 33 | 14 | M26999 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 3.73e-24 | 76 | 33 | 14 | MM14573 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 4.82e-23 | 90 | 33 | 14 | M631 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL11A2 COL16A1 COL17A1 | 8.47e-21 | 64 | 33 | 12 | M26953 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL11A2 COL17A1 | 6.91e-19 | 61 | 33 | 11 | M27103 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL3A1 COL4A3 COL4A4 COL4A6 COL7A1 COL8A2 COL11A1 COL11A2 COL16A1 COL17A1 | 4.20e-18 | 46 | 33 | 10 | M198 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL11A2 | 1.05e-17 | 50 | 33 | 10 | MM14796 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL11A2 | 1.99e-17 | 53 | 33 | 10 | MM14566 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL11A2 COL16A1 COL17A1 | 1.69e-16 | 140 | 33 | 12 | M587 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 2.00e-16 | 258 | 33 | 14 | MM14572 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL3A1 COL4A3 COL4A4 COL4A6 COL7A1 COL8A2 COL11A1 COL11A2 COL16A1 COL17A1 | 7.10e-16 | 74 | 33 | 10 | M160 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 1.65e-15 | 300 | 33 | 14 | M610 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.64e-15 | 32 | 33 | 8 | MM14924 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL11A2 | 6.34e-14 | 114 | 33 | 10 | MM14571 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL16A1 | 8.20e-14 | 76 | 33 | 9 | MM14867 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL16A1 | 2.34e-13 | 85 | 33 | 9 | M16441 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 7.36e-13 | 59 | 33 | 8 | M27218 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.38e-10 | 66 | 33 | 7 | M18 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.51e-10 | 15 | 33 | 5 | M27161 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 7.74e-10 | 20 | 33 | 5 | MM15061 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 7.79e-10 | 84 | 33 | 7 | M7098 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 5.17e-09 | 10 | 33 | 4 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 5.17e-09 | 10 | 33 | 4 | MM1560 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 7.00e-09 | 30 | 33 | 5 | M27216 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 8.12e-09 | 11 | 33 | 4 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.22e-08 | 12 | 33 | 4 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.75e-08 | 13 | 33 | 4 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.75e-08 | 13 | 33 | 4 | M12950 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.98e-08 | 76 | 33 | 6 | M27219 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.43e-08 | 38 | 33 | 5 | MM14969 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.45e-08 | 14 | 33 | 4 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.45e-08 | 14 | 33 | 4 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.33e-08 | 15 | 33 | 4 | MM14922 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 4.10e-08 | 42 | 33 | 5 | M7169 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 7.44e-08 | 18 | 33 | 4 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 7.44e-08 | 18 | 33 | 4 | MM14882 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 9.41e-08 | 19 | 33 | 4 | MM15512 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.17e-07 | 20 | 33 | 4 | M15394 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.97e-07 | 57 | 33 | 5 | MM14713 | |
| Pathway | WP_FOCAL_ADHESION | 2.06e-07 | 187 | 33 | 7 | MM15913 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.14e-07 | 23 | 33 | 4 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.14e-07 | 23 | 33 | 4 | MM1427 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.15e-07 | 58 | 33 | 5 | M2049 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.15e-07 | 199 | 33 | 7 | M7253 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.27e-07 | 63 | 33 | 5 | M11187 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 6.53e-07 | 30 | 33 | 4 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 6.53e-07 | 30 | 33 | 4 | MM15517 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.37e-06 | 41 | 33 | 4 | M27778 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 4.05e-06 | 418 | 33 | 8 | MM15587 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 5.12e-06 | 302 | 33 | 7 | M39719 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 8.44e-06 | 326 | 33 | 7 | MM15917 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.72e-05 | 67 | 33 | 4 | MM15345 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.35e-05 | 532 | 33 | 8 | M27870 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.77e-05 | 261 | 33 | 6 | MM15676 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.30e-05 | 79 | 33 | 4 | M27643 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 3.68e-05 | 28 | 33 | 3 | MM15957 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 7.10e-05 | 96 | 33 | 4 | M39834 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.33e-04 | 502 | 33 | 7 | MM14537 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.35e-04 | 43 | 33 | 3 | M39565 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.35e-04 | 43 | 33 | 3 | M53 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL3A1 GATA4 COL4A2 COL4A3 CDKN2A COL4A4 COL5A3 POU3F1 POU3F3 CEBPA CLTA | 2.67e-04 | 1432 | 33 | 11 | M509 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.07e-04 | 575 | 33 | 7 | M29853 | |
| Pathway | WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS | 4.08e-04 | 13 | 33 | 2 | M39753 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 5.18e-04 | 161 | 33 | 4 | M39770 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 8.82e-04 | 325 | 33 | 5 | M12868 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 8.86e-04 | 19 | 33 | 2 | M27221 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 9.79e-04 | 84 | 33 | 3 | M3228 | |
| Pathway | PID_CMYB_PATHWAY | 9.79e-04 | 84 | 33 | 3 | M195 | |
| Pathway | WP_CANCER_PATHWAYS | 1.02e-03 | 507 | 33 | 6 | M48302 | |
| Pathway | WP_FOCAL_ADHESION | 1.14e-03 | 199 | 33 | 4 | M39402 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 1.80e-03 | 27 | 33 | 2 | M27217 | |
| Pathway | WP_FAMILIAL_PARTIAL_LIPODYSTROPHY | 2.22e-03 | 30 | 33 | 2 | M42537 | |
| Pathway | WP_WHITE_FAT_CELL_DIFFERENTIATION | 2.52e-03 | 32 | 33 | 2 | M39333 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 2.68e-03 | 33 | 33 | 2 | M39875 | |
| Pathway | WP_WHITE_FAT_CELL_DIFFERENTIATION | 2.68e-03 | 33 | 33 | 2 | MM15869 | |
| Pathway | WP_FRAGILE_X_SYNDROME | 2.79e-03 | 121 | 33 | 3 | M39804 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 3.31e-03 | 439 | 33 | 5 | M42563 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 4.12e-03 | 41 | 33 | 2 | M29748 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 4.94e-03 | 45 | 33 | 2 | M39864 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 5.12e-03 | 301 | 33 | 4 | MM15983 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.38e-03 | 47 | 33 | 2 | MM14925 | |
| Pathway | WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER | 6.07e-03 | 50 | 33 | 2 | M39822 | |
| Pathway | WP_PI3KAKT_SIGNALING | 7.75e-03 | 339 | 33 | 4 | M39736 | |
| Pubmed | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL11A1 COL22A1 COL11A2 COL16A1 COL28A1 | 1.25e-18 | 175 | 41 | 12 | 28071719 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL3A1 COL4A2 COL4A3 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL11A2 COL16A1 COL28A1 | 5.69e-18 | 135 | 41 | 11 | 28675934 |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL3A1 COL4A2 COL4A3 COL4A6 COL5A3 COL7A1 COL11A2 COL16A1 COL17A1 | 3.32e-17 | 62 | 41 | 9 | 28344315 |
| Pubmed | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL7A1 COL8A2 COL16A1 COL17A1 COL28A1 | 2.01e-15 | 153 | 41 | 10 | 25037231 | |
| Pubmed | COL4A3 COL4A6 COL5A3 COL7A1 VAX1 COL11A1 COL11A2 COL16A1 COL17A1 | 2.66e-12 | 210 | 41 | 9 | 16537572 | |
| Pubmed | 1.99e-11 | 167 | 41 | 8 | 22159717 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 2.49e-11 | 6 | 41 | 4 | 9506531 | |
| Pubmed | 2.49e-11 | 6 | 41 | 4 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 2.49e-11 | 6 | 41 | 4 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 2.49e-11 | 6 | 41 | 4 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 2.49e-11 | 6 | 41 | 4 | 6389236 | |
| Pubmed | 2.49e-11 | 6 | 41 | 4 | 12225806 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 2.49e-11 | 6 | 41 | 4 | 10534397 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 2.49e-11 | 6 | 41 | 4 | 9673377 | |
| Pubmed | 2.49e-11 | 6 | 41 | 4 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 2.49e-11 | 6 | 41 | 4 | 19275937 | |
| Pubmed | 2.49e-11 | 6 | 41 | 4 | 6988303 | ||
| Pubmed | 3.55e-11 | 21 | 41 | 5 | 27856617 | ||
| Pubmed | 5.80e-11 | 7 | 41 | 4 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 5.80e-11 | 7 | 41 | 4 | 8006028 | |
| Pubmed | 5.80e-11 | 7 | 41 | 4 | 10416788 | ||
| Pubmed | 5.80e-11 | 7 | 41 | 4 | 1724753 | ||
| Pubmed | 1.16e-10 | 8 | 41 | 4 | 3997552 | ||
| Pubmed | 1.16e-10 | 8 | 41 | 4 | 29422532 | ||
| Pubmed | 1.16e-10 | 8 | 41 | 4 | 10382266 | ||
| Pubmed | 2.08e-10 | 9 | 41 | 4 | 9878537 | ||
| Pubmed | 2.08e-10 | 9 | 41 | 4 | 12101409 | ||
| Pubmed | 3.47e-10 | 10 | 41 | 4 | 9136074 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXD2 GATA4 MYCL SKOR1 POU3F1 VAX1 POU3F3 POU5F1B FOXK2 PHOX2B HSF5 KLF2 | 3.67e-10 | 908 | 41 | 12 | 19274049 |
| Pubmed | 5.45e-10 | 11 | 41 | 4 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 5.45e-10 | 11 | 41 | 4 | 7500359 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 8.17e-10 | 12 | 41 | 4 | 12180907 | |
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 8.17e-10 | 12 | 41 | 4 | 15837576 | |
| Pubmed | 8.17e-10 | 12 | 41 | 4 | 16024816 | ||
| Pubmed | 9.88e-10 | 39 | 41 | 5 | 33580754 | ||
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 3089234 | ||
| Pubmed | 1.65e-09 | 14 | 41 | 4 | 12878203 | ||
| Pubmed | 2.99e-09 | 16 | 41 | 4 | 15878328 | ||
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 6.08e-09 | 4 | 41 | 3 | 7827955 | |
| Pubmed | 6.36e-09 | 19 | 41 | 4 | 15689378 | ||
| Pubmed | 7.38e-09 | 709 | 41 | 10 | 22988430 | ||
| Pubmed | 1.52e-08 | 5 | 41 | 3 | 9409248 | ||
| Pubmed | 2.44e-08 | 26 | 41 | 4 | 24742657 | ||
| Pubmed | 3.03e-08 | 6 | 41 | 3 | 7495302 | ||
| Pubmed | 3.03e-08 | 6 | 41 | 3 | 23487795 | ||
| Pubmed | 3.03e-08 | 6 | 41 | 3 | 10722718 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 3.74e-08 | 79 | 41 | 5 | 18757743 | |
| Pubmed | 5.11e-08 | 31 | 41 | 4 | 22925884 | ||
| Pubmed | 5.30e-08 | 7 | 41 | 3 | 10639489 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 5.30e-08 | 7 | 41 | 3 | 10716744 | |
| Pubmed | 5.30e-08 | 7 | 41 | 3 | 7521231 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 8.48e-08 | 8 | 41 | 3 | 20059976 | |
| Pubmed | 8.48e-08 | 8 | 41 | 3 | 1377218 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 8.48e-08 | 8 | 41 | 3 | 11867580 | |
| Pubmed | 8.48e-08 | 8 | 41 | 3 | 11683410 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 8.48e-08 | 8 | 41 | 3 | 10970885 | |
| Pubmed | GATA4 COL4A4 NAT8L COL8A2 COL11A1 COL22A1 FOXK2 COL16A1 HSF5 | 8.87e-08 | 689 | 41 | 9 | 36543142 | |
| Pubmed | 1.27e-07 | 9 | 41 | 3 | 8562707 | ||
| Pubmed | 1.27e-07 | 9 | 41 | 3 | 10880400 | ||
| Pubmed | 1.27e-07 | 9 | 41 | 3 | 8995276 | ||
| Pubmed | 1.47e-07 | 40 | 41 | 4 | 27068110 | ||
| Pubmed | 1.81e-07 | 10 | 41 | 3 | 9415455 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 2.07e-07 | 544 | 41 | 8 | 28473536 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 2.49e-07 | 11 | 41 | 3 | 9731539 | |
| Pubmed | 3.32e-07 | 12 | 41 | 3 | 27292645 | ||
| Pubmed | RNA Pol II pausing facilitates phased pluripotency transitions by buffering transcription. | 3.32e-07 | 12 | 41 | 3 | 35981753 | |
| Pubmed | Murine chromosomal location of four class III POU transcription factors. | 3.32e-07 | 12 | 41 | 3 | 8276397 | |
| Pubmed | 3.32e-07 | 12 | 41 | 3 | 8918877 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 4.31e-07 | 13 | 41 | 3 | 9833687 | |
| Pubmed | Control of ground-state pluripotency by allelic regulation of Nanog. | 5.49e-07 | 14 | 41 | 3 | 22327294 | |
| Pubmed | 5.49e-07 | 14 | 41 | 3 | 19858219 | ||
| Pubmed | ZNRF3 functions in mammalian sex determination by inhibiting canonical WNT signaling. | 6.85e-07 | 15 | 41 | 3 | 29735715 | |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 6.85e-07 | 15 | 41 | 3 | 9832566 | |
| Pubmed | 6.85e-07 | 15 | 41 | 3 | 10625553 | ||
| Pubmed | 6.85e-07 | 15 | 41 | 3 | 9264260 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 6.85e-07 | 15 | 41 | 3 | 10706142 | |
| Pubmed | 1.23e-06 | 18 | 41 | 3 | 9160753 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 33348901 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 11780999 | ||
| Pubmed | Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family. | 1.36e-06 | 2 | 41 | 2 | 28674241 | |
| Pubmed | Identification of the nuclear localization signal of the POU domain protein Tst-1/Oct6. | 1.36e-06 | 2 | 41 | 2 | 8663425 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 9537506 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 26386639 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 7987396 | ||
| Pubmed | Heterozygous COL4A3/COL4A4 mutations: the hidden part of the iceberg? | 1.36e-06 | 2 | 41 | 2 | 35090027 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 29742505 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 38214412 | ||
| Pubmed | Differential in situ expression of alpha2(XI) collagen mRNA isoforms in the developing mouse. | 1.36e-06 | 2 | 41 | 2 | 9560475 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 2591970 | ||
| Pubmed | Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases. | 1.36e-06 | 2 | 41 | 2 | 17216251 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 35369551 | ||
| Pubmed | Immunohistochemical localization of collagen type XI alpha1 and alpha2 chains in human colon tissue. | 1.36e-06 | 2 | 41 | 2 | 18040076 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 25307543 | ||
| Pubmed | Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. | 1.36e-06 | 2 | 41 | 2 | 27281700 | |
| Pubmed | [From Alport syndrome to benign familial hematuria: clinical and genetic aspect]. | 1.36e-06 | 2 | 41 | 2 | 16895672 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 30443360 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 7560887 | ||
| Pubmed | COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. | 1.36e-06 | 2 | 41 | 2 | 24052634 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 19357112 | ||
| Pubmed | Collagen XI sequence variations in nonsyndromic cleft palate, Robin sequence and micrognathia. | 1.36e-06 | 2 | 41 | 2 | 12673280 | |
| Interaction | HABP2 interactions | 3.23e-08 | 18 | 38 | 4 | int:HABP2 | |
| Interaction | LAIR2 interactions | 3.26e-08 | 49 | 38 | 5 | int:LAIR2 | |
| Interaction | OSM interactions | 5.09e-08 | 20 | 38 | 4 | int:OSM | |
| Interaction | DCN interactions | 1.26e-06 | 43 | 38 | 4 | int:DCN | |
| Interaction | CD93 interactions | 1.51e-06 | 45 | 38 | 4 | int:CD93 | |
| Interaction | FN1 interactions | COL4A2 COL4A3 CDKN2A COL4A4 COL4A6 COL7A1 COL8A2 RBM12 SF1 CLTA | 2.67e-06 | 848 | 38 | 10 | int:FN1 |
| Interaction | SERPINE2 interactions | 3.68e-06 | 56 | 38 | 4 | int:SERPINE2 | |
| Interaction | FBLN2 interactions | 7.12e-06 | 66 | 38 | 4 | int:FBLN2 | |
| Interaction | MMP9 interactions | 7.56e-06 | 67 | 38 | 4 | int:MMP9 | |
| Interaction | TGFBI interactions | 1.38e-05 | 25 | 38 | 3 | int:TGFBI | |
| Interaction | ANTXR2 interactions | 2.18e-05 | 29 | 38 | 3 | int:ANTXR2 | |
| Interaction | POU3F4 interactions | 5.17e-05 | 6 | 38 | 2 | int:POU3F4 | |
| Interaction | MATN2 interactions | 5.97e-05 | 113 | 38 | 4 | int:MATN2 | |
| Interaction | COL8A2 interactions | 6.75e-05 | 42 | 38 | 3 | int:COL8A2 | |
| Interaction | C1QTNF1 interactions | 9.47e-05 | 47 | 38 | 3 | int:C1QTNF1 | |
| Interaction | NCOR2 interactions | 1.31e-04 | 264 | 38 | 5 | int:NCOR2 | |
| Interaction | SAA1 interactions | 1.44e-04 | 54 | 38 | 3 | int:SAA1 | |
| Interaction | ARHGEF19 interactions | 1.97e-04 | 60 | 38 | 3 | int:ARHGEF19 | |
| Interaction | P4HA1 interactions | 2.30e-04 | 298 | 38 | 5 | int:P4HA1 | |
| Interaction | PRNP interactions | GATA4 COL4A4 NAT8L COL8A2 COL11A1 COL22A1 FOXK2 COL16A1 HSF5 | 2.37e-04 | 1158 | 38 | 9 | int:PRNP |
| Interaction | COL2A1 interactions | 2.38e-04 | 64 | 38 | 3 | int:COL2A1 | |
| Interaction | ZBTB3 interactions | 2.38e-04 | 64 | 38 | 3 | int:ZBTB3 | |
| Interaction | COL5A1 interactions | 2.49e-04 | 65 | 38 | 3 | int:COL5A1 | |
| Interaction | COLGALT2 interactions | 2.73e-04 | 67 | 38 | 3 | int:COLGALT2 | |
| Interaction | EGR1 interactions | 3.37e-04 | 72 | 38 | 3 | int:EGR1 | |
| Interaction | PLOD3 interactions | 3.82e-04 | 183 | 38 | 4 | int:PLOD3 | |
| Interaction | LCORL interactions | 4.09e-04 | 16 | 38 | 2 | int:LCORL | |
| Interaction | COL1A2 interactions | 4.27e-04 | 78 | 38 | 3 | int:COL1A2 | |
| Cytoband | 1p34.2 | 1.20e-03 | 57 | 41 | 2 | 1p34.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 2.31e-03 | 294 | 41 | 3 | chr1p34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q36 | 2.65e-03 | 85 | 41 | 2 | chr2q36 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q24 | 3.93e-03 | 355 | 41 | 3 | chr8q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q25 | 6.16e-03 | 131 | 41 | 2 | chr10q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p35 | 6.72e-03 | 137 | 41 | 2 | chr1p35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p13 | 6.91e-03 | 139 | 41 | 2 | chr5p13 | |
| GeneFamily | Collagens | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 1.18e-28 | 46 | 35 | 14 | 490 |
| GeneFamily | POU class homeoboxes and pseudogenes | 1.15e-05 | 23 | 35 | 3 | 523 | |
| GeneFamily | Forkhead boxes | 3.13e-03 | 43 | 35 | 2 | 508 | |
| Coexpression | NABA_COLLAGENS | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 3.25e-30 | 43 | 41 | 14 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 COL28A1 | 4.77e-30 | 44 | 41 | 14 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 GLDN COL16A1 COL17A1 COL28A1 | 5.27e-20 | 270 | 41 | 15 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 GLDN COL16A1 COL17A1 COL28A1 | 6.96e-20 | 275 | 41 | 15 | M5884 |
| Coexpression | NABA_MATRISOME | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 GLDN COL16A1 COL17A1 COL28A1 | 1.33e-11 | 1008 | 41 | 15 | MM17056 |
| Coexpression | NABA_MATRISOME | COL3A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 GLDN COL16A1 COL17A1 COL28A1 | 1.71e-11 | 1026 | 41 | 15 | M5889 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 2.40e-10 | 23 | 41 | 5 | M48001 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 7.69e-10 | 200 | 41 | 8 | M5930 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 7.08e-08 | 6 | 41 | 3 | M48000 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 4.52e-07 | 40 | 41 | 4 | M5887 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 5.81e-07 | 11 | 41 | 3 | M47997 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 2.38e-06 | 17 | 41 | 3 | M47995 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 2.85e-06 | 18 | 41 | 3 | M47984 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 1.01e-05 | 27 | 41 | 3 | M47994 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.26e-05 | 29 | 41 | 3 | MM17055 | |
| Coexpression | URS_ADIPOCYTE_DIFFERENTIATION_DN | 1.55e-05 | 31 | 41 | 3 | M18395 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 2.11e-05 | 767 | 41 | 8 | M39209 | |
| Coexpression | CRX_DN.V1_DN | 5.39e-05 | 132 | 41 | 4 | M2792 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 1.03e-04 | 58 | 41 | 3 | M178 | |
| Coexpression | MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY | 1.07e-04 | 10 | 41 | 2 | MM1261 | |
| Coexpression | MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY | 1.07e-04 | 10 | 41 | 2 | M1928 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 1.22e-04 | 163 | 41 | 4 | M2769 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 1.26e-04 | 62 | 41 | 3 | M16774 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED | 1.56e-04 | 12 | 41 | 2 | M47983 | |
| Coexpression | RIZKI_TUMOR_INVASIVENESS_2D_UP | 1.73e-04 | 69 | 41 | 3 | M4242 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.89e-04 | 71 | 41 | 3 | M3955 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 2.13e-04 | 74 | 41 | 3 | M13547 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 2.14e-04 | 352 | 41 | 5 | M17471 | |
| Coexpression | BRUECKNER_TARGETS_OF_MIRLET7A3_DN | 2.31e-04 | 76 | 41 | 3 | M11825 | |
| Coexpression | P53_DN.V1_UP | 2.38e-04 | 194 | 41 | 4 | M2698 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 2.47e-04 | 15 | 41 | 2 | MM402 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 2.62e-04 | 199 | 41 | 4 | M7259 | |
| Coexpression | GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN | 2.67e-04 | 200 | 41 | 4 | M9067 | |
| Coexpression | GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP | 2.67e-04 | 200 | 41 | 4 | M7802 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | 2.86e-04 | 1115 | 41 | 8 | M10371 | |
| Coexpression | DESCARTES_FETAL_INTESTINE_MESOTHELIAL_CELLS | 3.55e-04 | 88 | 41 | 3 | M40217 | |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN | 4.18e-04 | 93 | 41 | 3 | M4752 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL | 4.73e-04 | 97 | 41 | 3 | M45794 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 4.73e-04 | 909 | 41 | 7 | M41018 | |
| Coexpression | BENPORATH_PRC2_TARGETS | 4.88e-04 | 650 | 41 | 6 | M8448 | |
| Coexpression | HU_ANGIOGENESIS_UP | 4.92e-04 | 21 | 41 | 2 | M6967 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 5.82e-04 | 438 | 41 | 5 | M1954 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 5.94e-04 | 440 | 41 | 5 | MM832 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER | 7.00e-04 | 25 | 41 | 2 | M47986 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 7.01e-04 | 111 | 41 | 3 | M45685 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_DN | 7.18e-04 | 459 | 41 | 5 | M38993 | |
| CoexpressionAtlas | kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_top-relative-expression-ranked_1000 | 1.20e-06 | 608 | 39 | 9 | gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_1000 | |
| CoexpressionAtlas | kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.98e-06 | 475 | 39 | 8 | gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_k1_1000 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | COL3A1 COL4A2 CDKN2A COL5A3 POU3F3 COL8A2 COL11A1 COL11A2 GRIN2D PHOX2B | 6.02e-06 | 951 | 39 | 10 | Arv_EB-LF_2500_K2 |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-08 | 168 | 41 | 6 | af82e07d1eec51fc6530155f37addbce6221885d | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-08 | 179 | 41 | 6 | 3d6bb3cfe89d60f2f00aead9341f9967e5313763 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.61e-08 | 182 | 41 | 6 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.08e-08 | 190 | 41 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-08 | 191 | 41 | 6 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-08 | 192 | 41 | 6 | b35f0e422070ba9c7c1d9ff3eace4edc10286cde | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-08 | 198 | 41 | 6 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-08 | 198 | 41 | 6 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-08 | 199 | 41 | 6 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Abcc9_(Mural.Rgs5Acta2.Abcc9)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.81e-08 | 102 | 41 | 5 | 8c4d9483ff983538593f4e17f4a74a93cdda59c4 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Abcc9_(Mural.Rgs5Acta2.Abcc9)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.81e-08 | 102 | 41 | 5 | 72ce247dad7404e6b9c971b5c29d3c6846da5efc | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.81e-08 | 102 | 41 | 5 | 5feedce6d26a578c4aaba4e4824b3d0c3f3806bc | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.85e-08 | 107 | 41 | 5 | d446ffbe93cd49669f1cf91411aae07cc15d9e2a | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.85e-08 | 107 | 41 | 5 | 5c9e745d0b08a4aa1f3a93f9cc094fac57061a30 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.37e-08 | 113 | 41 | 5 | 0651fb7a7e1ea84b8365059e5ed85bf6c082da1a | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8-MURAL_Mural.Acta2Rgs5.Kcnj8-Abcc9_(Mural.Acta2Rgs5.Kcnj8-Abcc9)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.37e-08 | 113 | 41 | 5 | 0e153efddd061d7510dfc3859cc8b1a7984fa70e | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.61e-08 | 120 | 41 | 5 | e60b74758c8290919b326904ad841962256b72ec | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.61e-08 | 120 | 41 | 5 | 3e1ae5a5422729d484a90d72f779833fe3473fa8 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.61e-08 | 120 | 41 | 5 | 24d5e86931a857bb87684392172bf04294a1a46a | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.39e-07 | 132 | 41 | 5 | 560e836764ed7806fb18282dfebe434d30112a9a | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.50e-07 | 159 | 41 | 5 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.20e-07 | 165 | 41 | 5 | 570483b43ccb5831feec9337b4664814431d40b1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.20e-07 | 165 | 41 | 5 | 2026a9a07f4d314cc05c167e491312b373468e46 | |
| ToppCell | Basal_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.33e-07 | 166 | 41 | 5 | 23c04d1fba0c1733ccd0e4378fae2edde4fd0a7b | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.29e-07 | 179 | 41 | 5 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.46e-07 | 180 | 41 | 5 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.46e-07 | 180 | 41 | 5 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.46e-07 | 180 | 41 | 5 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.64e-07 | 181 | 41 | 5 | 634a4f4e5942473e60d08d0b0936407b04bc6b7c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.64e-07 | 181 | 41 | 5 | c2938cf1f5d4875be07a56a1f36c94f8eab37d99 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.01e-07 | 183 | 41 | 5 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.01e-07 | 183 | 41 | 5 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.01e-07 | 183 | 41 | 5 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.20e-07 | 184 | 41 | 5 | 8880ff36c243cc60a524d74934d000aef26a70ac | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-07 | 185 | 41 | 5 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.40e-07 | 185 | 41 | 5 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-07 | 185 | 41 | 5 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-07 | 186 | 41 | 5 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.01e-07 | 188 | 41 | 5 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.01e-07 | 188 | 41 | 5 | 5a89587ee6f2b4dc14244bd88bb31efb81c50dbe | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 8.01e-07 | 188 | 41 | 5 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 8.22e-07 | 189 | 41 | 5 | 4178be3292ff4a8a1d8098f638d4b8d15164d2c6 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.44e-07 | 190 | 41 | 5 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.66e-07 | 191 | 41 | 5 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.66e-07 | 191 | 41 | 5 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.66e-07 | 191 | 41 | 5 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-07 | 192 | 41 | 5 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 8.89e-07 | 192 | 41 | 5 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-H_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.89e-07 | 192 | 41 | 5 | 7a6dd2ae217b8f8e460d47ad128904408299458c | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-07 | 192 | 41 | 5 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-07 | 193 | 41 | 5 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.12e-07 | 193 | 41 | 5 | df4afb4848eb9d7d8d39e5c612919663cbbb2514 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.12e-07 | 193 | 41 | 5 | ab36d684bde8fe77d11a5188425135328052c58b | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 9.12e-07 | 193 | 41 | 5 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-07 | 194 | 41 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.35e-07 | 194 | 41 | 5 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.59e-07 | 195 | 41 | 5 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-07 | 195 | 41 | 5 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-07 | 195 | 41 | 5 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.84e-07 | 196 | 41 | 5 | f40d10ea7714067585493fdc89744714aa427de8 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-07 | 196 | 41 | 5 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.84e-07 | 196 | 41 | 5 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-07 | 196 | 41 | 5 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.84e-07 | 196 | 41 | 5 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.84e-07 | 196 | 41 | 5 | b8350340d86e4524e9616a427e7f2e116a6fb3be | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 197 | 41 | 5 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 197 | 41 | 5 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.03e-06 | 198 | 41 | 5 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.03e-06 | 198 | 41 | 5 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-06 | 198 | 41 | 5 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-06 | 198 | 41 | 5 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-06 | 198 | 41 | 5 | 52ddc1f1ed4ac4c3bac794c90b8feb03e3c221c4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 198 | 41 | 5 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 199 | 41 | 5 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 199 | 41 | 5 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 199 | 41 | 5 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | 18-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 1.06e-06 | 199 | 41 | 5 | f5d0aa4170367c080d3c2f01d9af3529762917fa | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-06 | 199 | 41 | 5 | 2e7f517c0444b4f29ff11c26ab32e9cc0f7e99ef | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 199 | 41 | 5 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 199 | 41 | 5 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-06 | 200 | 41 | 5 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-06 | 200 | 41 | 5 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-06 | 200 | 41 | 5 | d254f6634895486f81d7a8b6f006fbc2679eaa5b | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-06 | 200 | 41 | 5 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-06 | 200 | 41 | 5 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Biopsy_IPF-Epithelial-KRT5-/KRT17+|Biopsy_IPF / Sample group, Lineage and Cell type | 1.09e-06 | 200 | 41 | 5 | 2fc7a3b3aea711ad3d96fd9513f4b40533056d86 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-06 | 200 | 41 | 5 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.65e-06 | 105 | 41 | 4 | c7528276fee8f6d2cb4639069bc87413b0288025 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.65e-06 | 105 | 41 | 4 | 7bcf3345a21a1ade717128be127e9fe12ae40011 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.65e-06 | 105 | 41 | 4 | 62e89b92bb8c5187ab0205aebd018b4178710bb0 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.43e-06 | 112 | 41 | 4 | 88fcd0dc12b5c00804381fb7dd59a6a2a9f37419 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.43e-06 | 112 | 41 | 4 | fd4cc5190626cb262aae0a7f04559b0e9757270e | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.43e-06 | 112 | 41 | 4 | d652e6fae433a6b56bf2a448fba2cf6c5e558905 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn-Endothelial_Tip.Dcn.Nenf_(Nenf)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.68e-06 | 114 | 41 | 4 | 7be16e7f7b9c9dbd68933ace3b7f8f661bed41a7 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.68e-06 | 114 | 41 | 4 | f4bdfc47418d22a49e0c4a6c3bd0663e15fb53bb | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.67e-06 | 121 | 41 | 4 | 5035e071033cb76a7fc0128716755b14821e8f05 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.67e-06 | 121 | 41 | 4 | c96115bd33455296378a257583b49442d00b39ca | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.48e-06 | 126 | 41 | 4 | f1f24b06d301c266226d1a59dd28585f5ac68f29 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.48e-06 | 126 | 41 | 4 | fe6900eb37e4f09465a1276586c73dd38545fa2a | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.48e-06 | 126 | 41 | 4 | 3d507f829882d043f633db2612b76936e2042445 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.03e-04 | 50 | 25 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | Adhesion molecules. | 2.90e-04 | 141 | 25 | 4 | MODULE_122 | |
| Drug | GK-101 | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 2.68e-20 | 36 | 41 | 10 | CID000161853 |
| Drug | Madecassol | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 4.25e-19 | 46 | 41 | 10 | CID000108062 |
| Drug | d-indobufen | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 1.06e-18 | 50 | 41 | 10 | CID000044562 |
| Drug | ridogrel | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 1.64e-18 | 52 | 41 | 10 | CID005362391 |
| Drug | NSC49633 | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 2.01e-18 | 53 | 41 | 10 | CID000023340 |
| Drug | AC1LAKND | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 1.10e-17 | 62 | 41 | 10 | CID000470146 |
| Drug | BAPN | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 4.66e-17 | 71 | 41 | 10 | CID000001647 |
| Drug | malotilate | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 4.66e-17 | 71 | 41 | 10 | CID000004006 |
| Drug | AC1NMZ1B | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 8.33e-17 | 75 | 41 | 10 | CID005034185 |
| Drug | strontium ranelate | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 1.10e-16 | 77 | 41 | 10 | CID006918182 |
| Drug | halofuginone lactate | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 3.10e-16 | 85 | 41 | 10 | CID000062891 |
| Drug | DMSe | COL3A1 COL4A3 COL4A6 COL5A3 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 4.43e-16 | 132 | 41 | 11 | CID000020796 |
| Drug | 4-hydroxyproline | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 6.33e-16 | 91 | 41 | 10 | CID000000825 |
| Drug | pirfenidone | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 FOXK2 COL16A1 COL17A1 | 7.32e-16 | 138 | 41 | 11 | CID000040632 |
| Drug | candesartan cilexetil | COL3A1 GATA4 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 1.28e-15 | 145 | 41 | 11 | CID000002540 |
| Drug | ticlopidine | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 2.29e-15 | 103 | 41 | 10 | CID000005472 |
| Drug | hydroxylysine | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 4.11e-15 | 109 | 41 | 10 | CID000001029 |
| Drug | AC1L1C2F | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 4.51e-15 | 110 | 41 | 10 | CID000001711 |
| Drug | PPACK | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 5.95e-15 | 113 | 41 | 10 | CID003036757 |
| Drug | AC1L9732 | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 6.51e-15 | 114 | 41 | 10 | CID000439300 |
| Drug | Tranilast sodium | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 7.13e-15 | 115 | 41 | 10 | CID000005527 |
| Drug | Selara | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 1.67e-14 | 125 | 41 | 10 | CID000150310 |
| Drug | DL-penicillamine | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 4.94e-14 | 139 | 41 | 10 | CID000004727 |
| Drug | PCR 4099 | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 4.94e-14 | 139 | 41 | 10 | CID000002806 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 2.33e-13 | 162 | 41 | 10 | CID000072363 |
| Drug | khellin | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 4.02e-13 | 171 | 41 | 10 | CID000003828 |
| Drug | AC1L1DD6 | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 6.36e-13 | 179 | 41 | 10 | CID000002299 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 1.10e-12 | 189 | 41 | 10 | CID000001413 |
| Drug | foscarnet | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 1.16e-12 | 190 | 41 | 10 | CID000003414 |
| Drug | losartan | COL3A1 GATA4 COL4A3 COL4A6 COL7A1 ZFR COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 1.89e-12 | 378 | 41 | 12 | CID000003961 |
| Drug | AC1Q6PCP | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 7.76e-12 | 230 | 41 | 10 | CID000005267 |
| Drug | prostacyclin sodium salt | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 1.77e-11 | 250 | 41 | 10 | CID000000159 |
| Drug | hyaluronan | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 2.92e-11 | 263 | 41 | 10 | CID000024759 |
| Drug | silibinin | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 6.42e-11 | 285 | 41 | 10 | CID000005213 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 1.66e-10 | 314 | 41 | 10 | CID000447989 |
| Drug | AC1L18QD | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 2.32e-10 | 325 | 41 | 10 | CID000000213 |
| Drug | Y-27632 | COL3A1 GATA4 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 2.56e-10 | 444 | 41 | 11 | CID000005711 |
| Drug | colchine | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 1.14e-09 | 383 | 41 | 10 | CID000002833 |
| Drug | chondroitin sulfate | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 2.35e-09 | 413 | 41 | 10 | CID000024766 |
| Drug | L-3,4-dehydroproline | 3.62e-09 | 73 | 41 | 6 | CID000094284 | |
| Drug | AC1L1KMJ | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 9.11e-09 | 476 | 41 | 10 | CID000030956 |
| Drug | aspirin | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 4.44e-08 | 563 | 41 | 10 | CID000002244 |
| Drug | LMWH | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 2.03e-07 | 663 | 41 | 10 | CID000000772 |
| Drug | isodesmosine | 3.56e-07 | 33 | 41 | 4 | CID000013811 | |
| Drug | PD123177 | 1.06e-06 | 43 | 41 | 4 | CID000114899 | |
| Drug | NC-4 | 1.17e-06 | 44 | 41 | 4 | CID006420119 | |
| Drug | LS-63783 | COL3A1 COL4A3 COL4A6 COL7A1 COL8A2 COL11A1 COL22A1 COL11A2 COL16A1 COL17A1 | 1.18e-06 | 804 | 41 | 10 | CID000000231 |
| Drug | Phenelzine sulfate [156-51-4]; Up 200; 17uM; PC3; HT_HG-U133A | 1.40e-06 | 198 | 41 | 6 | 3802_UP | |
| Drug | Fenbendazole [43210-67-9]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.44e-06 | 199 | 41 | 6 | 3805_UP | |
| Drug | desmosine | 2.49e-06 | 53 | 41 | 4 | CID000025435 | |
| Drug | 351A | 6.05e-06 | 20 | 41 | 3 | CID000122144 | |
| Drug | ATFP | 1.89e-05 | 4 | 41 | 2 | CID000193783 | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.81e-05 | 199 | 41 | 5 | 3625_UP | |
| Drug | Delsoline [509-18-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.88e-05 | 200 | 41 | 5 | 6075_UP | |
| Drug | 17-isoprogesterone | COL3A1 GATA4 COL4A3 COL7A1 ZFR COL8A2 COL11A1 COL11A2 GRIN2D COL16A1 | 3.22e-05 | 1170 | 41 | 10 | CID000004920 |
| Drug | BPAT-143 | 4.72e-05 | 6 | 41 | 2 | CID000146249 | |
| Drug | Diphosphonates | 4.72e-05 | 6 | 41 | 2 | ctd:D004164 | |
| Drug | kalinin | 1.33e-04 | 55 | 41 | 3 | CID000032518 | |
| Drug | 1h00 | 1.41e-04 | 56 | 41 | 3 | CID000445950 | |
| Drug | AC1L9INI | 1.64e-04 | 59 | 41 | 3 | CID000445839 | |
| Drug | 4-aminoazobenzene | 2.29e-04 | 66 | 41 | 3 | CID000006051 | |
| Drug | Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.86e-04 | 177 | 41 | 4 | 4164_UP | |
| Drug | 5-Acetamido-5,6-Dihydro-4-Hydroxy-6-Isobutoxy-4h-Pyran-2-Carboxylic Acid | 3.09e-04 | 73 | 41 | 3 | CID011963505 | |
| Drug | Cantharidin [56-25-7]; Down 200; 20.4uM; HL60; HT_HG-U133A | 3.52e-04 | 187 | 41 | 4 | 3075_DN | |
| Drug | NOC 18 | 3.74e-04 | 16 | 41 | 2 | ctd:C093285 | |
| Drug | 17-DMAG; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.74e-04 | 190 | 41 | 4 | 4437_UP | |
| Drug | Perphenazine [58-39-9]; Up 200; 10uM; HL60; HG-U133A | 3.97e-04 | 193 | 41 | 4 | 2040_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; PC3; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 3785_UP | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; HL60; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 2185_DN | |
| Drug | Piromidic acid [19562-30-2]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 3335_UP | |
| Drug | sulindac sulfide; Down 200; 50uM; MCF7; HG-U133A | 4.29e-04 | 197 | 41 | 4 | 308_DN | |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 3364_UP | |
| Drug | Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 3621_UP | |
| Drug | celecoxib; Down 200; 10uM; PC3; HG-U133A | 4.29e-04 | 197 | 41 | 4 | 482_DN | |
| Drug | staurosporine; Up 200; 0.01uM; SKMEL5; HG-U133A | 4.29e-04 | 197 | 41 | 4 | 508_UP | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 7003_DN | |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; HL60; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 2979_UP | |
| Drug | Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 4171_UP | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; PC3; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 3756_UP | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; PC3; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 4293_UP | |
| Drug | sulindac sulfone; Down 200; 50uM; MCF7; HG-U133A | 4.45e-04 | 199 | 41 | 4 | 309_DN | |
| Drug | Atovaquone [95233-18-4]; Up 200; 11uM; PC3; HT_HG-U133A | 4.45e-04 | 199 | 41 | 4 | 4201_UP | |
| Drug | Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; HL60; HT_HG-U133A | 4.54e-04 | 200 | 41 | 4 | 2395_UP | |
| Drug | Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 4.54e-04 | 200 | 41 | 4 | 5626_UP | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; PC3; HT_HG-U133A | 4.54e-04 | 200 | 41 | 4 | 5828_DN | |
| Drug | Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 4.54e-04 | 200 | 41 | 4 | 6477_UP | |
| Drug | AC1L9IU6 | 4.75e-04 | 18 | 41 | 2 | CID000445952 | |
| Drug | pyrachlostrobin | 5.54e-04 | 811 | 41 | 7 | ctd:C513428 | |
| Disease | collagen disease (implicated_via_orthology) | 5.03e-07 | 12 | 40 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | benign familial hematuria (is_implicated_in) | 1.79e-06 | 2 | 40 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | Fibrochondrogenesis | 1.79e-06 | 2 | 40 | 2 | C0265282 | |
| Disease | Alport syndrome, recessive type | 1.79e-06 | 2 | 40 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 1.79e-06 | 2 | 40 | 2 | C2931253 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 1.79e-06 | 2 | 40 | 2 | C4746745 | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 1.79e-06 | 2 | 40 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 1.79e-06 | 2 | 40 | 2 | C0403440 | |
| Disease | Benign familial hematuria | 1.79e-06 | 2 | 40 | 2 | cv:C0241908 | |
| Disease | Stickler syndrome (implicated_via_orthology) | 1.79e-06 | 2 | 40 | 2 | DOID:0080046 (implicated_via_orthology) | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 5.37e-06 | 3 | 40 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Alport syndrome | 5.37e-06 | 3 | 40 | 2 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 5.37e-06 | 3 | 40 | 2 | cv:CN076135 | |
| Disease | Hematuria, Benign Familial | 1.07e-05 | 4 | 40 | 2 | C0241908 | |
| Disease | Alport Syndrome | 1.07e-05 | 4 | 40 | 2 | C1567741 | |
| Disease | Stickler syndrome | 1.79e-05 | 5 | 40 | 2 | cv:C0265253 | |
| Disease | Alport Syndrome, X-Linked | 1.79e-05 | 5 | 40 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 1.79e-05 | 5 | 40 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 1.79e-05 | 5 | 40 | 2 | C1567744 | |
| Disease | end stage renal disease (is_implicated_in) | 2.37e-05 | 41 | 40 | 3 | DOID:783 (is_implicated_in) | |
| Disease | hypertensive nephropathy | 2.68e-05 | 6 | 40 | 2 | C0848548 | |
| Disease | myopathy (implicated_via_orthology) | 3.83e-05 | 48 | 40 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Hereditary hearing loss and deafness | 4.58e-05 | 146 | 40 | 4 | cv:C0236038 | |
| Disease | Small cell carcinoma of lung | 5.46e-05 | 54 | 40 | 3 | C0149925 | |
| Disease | neuroblastoma (is_implicated_in) | 8.01e-05 | 10 | 40 | 2 | DOID:769 (is_implicated_in) | |
| Disease | albuminuria | 2.84e-04 | 94 | 40 | 3 | EFO_0004285 | |
| Disease | Renal glomerular disease | 4.45e-04 | 23 | 40 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 4.45e-04 | 23 | 40 | 2 | C4521256 | |
| Disease | Neck Neoplasms | 5.27e-04 | 25 | 40 | 2 | C0027533 | |
| Disease | lifestyle measurement, maximum cigarettes per day measurement | 6.09e-04 | 122 | 40 | 3 | EFO_0009264, EFO_0010724 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GAPGPAGPAGLPGHQ | 836 | Q9UMD9 | |
| GHPGPPGLPGNGLPG | 611 | Q14031 | |
| GPPGDHGLPGYLGSP | 446 | Q01955 | |
| GQPGPPGHLGPAGPE | 1086 | Q01955 | |
| PGHLGPAGPEGAPGS | 1091 | Q01955 | |
| HPGAPGPSGSPGLPG | 1411 | Q07092 | |
| PGGLPGHAGGAAPGR | 101 | Q8N726 | |
| PGGRGALGPGGPLGH | 151 | P53420 | |
| ALGPGGPLGHPGEKG | 156 | P53420 | |
| GLGFPGPPGERGHPG | 631 | P53420 | |
| GPPGSSGPPGCPGDH | 1121 | P53420 | |
| GLDGFPGLPGPPGDG | 581 | P08572 | |
| SGPPGPPGAGGLPGH | 141 | Q6ZMI3 | |
| PPGAGGLPGHNGLDG | 146 | Q6ZMI3 | |
| PGHLGGPPAFGPGPG | 816 | Q9NTZ6 | |
| FSPPPGGGGDGPWGA | 11 | Q06416 | |
| PGGGGHGGAAPELPP | 86 | Q01167 | |
| GLAGLPGADGPPGHP | 721 | P12107 | |
| GDGPHGPPGERGLPG | 866 | P13942 | |
| GPGGGAGGTGPLMHP | 11 | Q03052 | |
| GPPAGGGPYGHPNPG | 56 | Q9UBV8 | |
| GPGPCGPPPGHGPGH | 61 | C9JFL3 | |
| HGPPPGAYEAGGPGA | 11 | P43694 | |
| DPGDPGPPGTHGNPG | 246 | Q2UY09 | |
| GGAVMPGGAHGPPPG | 116 | P49715 | |
| PGGAHGPPPGYGCAA | 121 | P49715 | |
| GLHGQPGPAGPPGFS | 106 | P25067 | |
| ETGPAGHPGLPGPPG | 1586 | Q8NFW1 | |
| ENGSPGAPGAPGHPG | 1036 | P02461 | |
| PGPVGGHGDPGPPGA | 2176 | Q02388 | |
| GHGDPGPPGAPGLAG | 2181 | Q02388 | |
| PPHHGGGGGGAGPGL | 291 | P20264 | |
| PGSDGPLGHPGHEGP | 676 | P25940 | |
| GPAGHPGPPGADGAQ | 1106 | P25940 | |
| GAAGPGPGPPSGGAA | 106 | O60548 | |
| LPDGAPPGHPPGSGG | 56 | Q9NSD7 | |
| GPGGGKPAGNGPLHH | 96 | Q4G112 | |
| PGASHLPPGAGAGPG | 441 | P84550 | |
| GAGAGHPGAGGAQPP | 71 | Q13884 | |
| DGGAPGPQPHGEPPG | 56 | P09496 | |
| GLGPGAGDPAPGIGP | 46 | P12524 | |
| PPGGHGGGGGHGPPS | 941 | Q96PV0 | |
| DPGAPGGPGGAEGPM | 181 | Q16763 | |
| DGGYPHGPPGPLGLL | 686 | Q96KR1 | |
| GGPSPAGAPGAAGPG | 216 | Q99453 | |
| GPGGPGGGPHSFPHP | 386 | Q15637 | |
| PGPGPAGPGGLHAGA | 251 | Q5SQQ9 | |
| PFGGPGFGAPGPGLH | 196 | Q9Y5W3 | |
| AQPHGGAGGAGPPGG | 61 | Q8N9F0 | |
| GTGGAGGGAPAAPPP | 1081 | O15399 |